Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
fourrunner
Jimboslice
Who wants to bet that these two jerks are the same person posting on this board
Oh by the way don't forget to tell the SEC about S Davis false pr that CSO file papers with the FDA
and then months later said that CSO didn't file the papers with the FDA
Have a nice day
Where are you little star
This press release may contain certain "forward-looking statements" relating to the business All statements, other than statements of historical fact included herein are "forward-looking statements"
Lots of luck
You believe it
Stupid
The stupid ones were those who believed it
You are all dying to here any good news that you jump on anything someone would tells you
YOU HAVE TO ADMIT I DID BRING EXCITEMENT TO THE BOARD
IS IT LEGAL FOR MR DAVIS TO TAKE YOUR MONEY ? GET OVER IT ASS----
IS IT LEGAL
Public Workshop - FDA/American Glaucoma Society Workshop on the Validity, Reliability, and Usability of Glaucoma Imaging Devices, October 5, 2012
Usability of Glaucoma Imaging Devices
Usability of Glaucoma Imaging Devices
Usability of Glaucoma Imaging Devices
Usability of Glaucoma Imaging Devices
HMMM I wonder HMMM
MAYBE
Here is some more news I will share with this board
Mr. Davis is Jimboslice
The news was release yesterday and today
Only I have this news and I am sharing it with this board
that is why you don't see it anywhere else
Oct. 03 2012
SALT LAKE CITY, UT-- Paradigm Medical Industries, Inc. (Pinksheets:PDMI - News) announced today that it
has been notified by its Italian partner, Costruzione Strumenti Oftalmici (CSO),that. Paradigm will be the exclusive representative for the Retimaxâ„¢, also known as the Paramax. in the U.S. market. "This new innovative device offers the earliest detection of glaucoma currently available and will be an excellent addition to Paradigm's glaucoma diagnostic products," said Stephen Davis, Paradigm's President and Chief Executive Officer.
The Paramax (as it will be known in the United States) represents the
third product that Paradigm represents for CSO. Paradigm also
represents CSO's impressive corneal topographer, known in the U.S. as
the Paravue 300, and CSO's corneal topographer with Scheimpflug
rotating camera, known in the U.S. as the Surveyor 500. Paradigm plans
to begin active promotion of the Paramax immediately
SALT LAKE CITY, UT--(Marketwire - 10/02/2012)- Paradigm Medical
Industries, Inc. (Pinksheets:PDMI - News) announced today that it has
been notified by its Italian partner, Costruzione Strumenti Oftalmici
(CSO), that. Paradigm will be the exclusive representative for the
Retimaxâ„¢, also known as the Paramax. in the U.S. market. "This new
innovative device offers the earliest detection of glaucoma currently
available and will be an excellent addition to Paradigm's glaucoma
diagnostic products," said Stephen Davis, Paradigm's President and
Chief Executive Officer.
The Paramax (as it will be known in the United States) represents the
third product that Paradigm represents for CSO. Paradigm also
represents CSO's impressive corneal topographer, known in the U.S. as
the Paravue 300, and CSO's corneal topographer with Scheimpflug
rotating camera, known in the U.S. as the Surveyor 500. Paradigm plans
to begin active promotion of the Paramax immediately
Jimboslice
I not sure but maybe it was Jimboslice
As far as the news if I try to post it they delete it
Maybe the M M don't want you to get the news before they make their move
I don't know
The news message was posted under #19813
You will see it was deleted
Someone just deleted the news that I just posted
And they are stopping me from posting the positive news I just was given
For some reason they do not want you to know what I am trying to tell you
)
SALT LAKE CITY, UT--(Marketwire - 10/02/2012 - Paradigm Medical Industries, Inc. (Pinksheets:PDMI - News) announced today that it has been notified by its Italian partner, Costruzione Strumenti Oftalmici (CSO), that Paradigm will be the exclusive representative for the Retimaxâ„¢, also known as the Paramax in the U.S. market. "This new innovative device offers the earliest detection of glaucoma currently available and will be an excellent addition to Paradigm's glaucoma diagnostic products," said Stephen Davis, Paradigm's President and Chief Executive Officer.
Good news yes
Maybe when the news comes out over the news wires
PDMI will make a big move
We can only hope
good luck
You won't see it
It has not been release yet
CSO Costruzione Strumenti Oftalmici S.r.l. Key Developments
Costruzione Strumenti Moves Closer To FDA Approval
Oct 01 2012
Paradigm Medical Industries Inc. announced that it had received notification from its Italian partner, CSO Costruzione Strumenti Oftalmici S.r.l., which manufactures the Paramax(TM), that it has U.S. Food and Drug Administration (FDA) 510(k) approval for the Paramax(TM). The Paramax(TM) is the next generation of standard ocular eletrophysiology utilized for early glaucoma detection. Paradigm will begin marketing and selling the Paramax(TM) in the United States upon receipt of the 510(k) approval.
Costruzione Strumenti OftalmiciNEWS
They have received notice from the FDA for approval of Paramax/Retimax
S.Davis will be making the announcement as soon as CSO gives him permission to do so
Will the real S Davis come out
Yes it is you Gainsmaker
I knew it
Gainmaker
we know that you know that you are the real S.Davis
Check out Barchart.com opinon on pdmi
Fri.28 2012
what a day it will be ,we been waiting a long time for this day
good luck to all
Could get earnings on Sept 30 2012
LOOKS LIKE WE ARE GOING HIGHER
NO ONE IS SELLING AT $0.0001 ,NEXT STOP $0.0003
Have you guys notice how the bid vol is picking up BIG TIME
That tells you people are trying to get in before the news comes out Fri
Good times coming FRI
BUY BEFORE THE FRI.
PARTY
I did not say the FDA list will be out on Oct 12 I said the list should be out by Oct 12
The FDA approval will be at the end of Sept
Sept 2012 FDA approval list should be out by Oct 12 2012
I REMEMBER WHEN IT WAS $ 8.00 A SHARE
SILVER SPRING, Md., Aug. 14, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (SNPK:$0.05,00$0.0018,3.73%) (the "Company" or "Sunpeaks Ventures (SNPK:$0.05,00$0.0018,3.73%) ") on 8/14/12 reported its financial results for the second quarter ended June 30, 2012:
Second Quarter Financial Details and Operating Summary
Gross sales for the second quarter were $1.23 mln on a non-adjusted basis. Gross sales for the year-to-date were $2.19mln on a non-adjusted basis. Second quarter revenue in 2012 represents a 4,000% increase over revenue for the same quarter in 2012, and a 29% increase over revenue for the first quarter of 2012.
The Company continues to grow its pharmaceutical license base and is now licensed in 30 states.
The Company continues to make a significant investment in its IT infrastructure, which management believes will stream line sales processes and lead to greater efficiencies.
The Company attended the ERCM Marketgate, Vitamin, Diet and Nutrition conference in Ft. Lauderdale, FL, and as a result expects to enter into new agreements regarding the distribution of Clotamin sometime in the second half of 2012.
FDA Aug. 2012 approval list is out
No Paramax on the list
But we knew that
Like I said we will see FDA
approval on 2012 Sept. list
GAINSMAKER
THAT $0.07 WAS AFTER A 1 FOR 100 SHARE R/S SPLIT
I forgot
Mr. Davis also said in his e-mail he is starting to see light at the end of the tunnel, earnings are starting to improve which you will see in the next earnings report
Just got a answer to my email to Mr Davis ONLY TOOK 3 MONTHS
In the email I ask him if the papers were submitted to the FDA
He say yes and also added he expects an answer from the FDA soon
Period Ending Mar 31, 2012 Dec 31, 2011 Mar 31, 2011
Total Revenue 181 221 196
Cost of Revenue 53 62 72
Gross Profit 128 159 124
Period Ending Mar 31, 2012 Dec 31, 2011 Mar 31, 2011
Total Revenue 181 221 196
Cost of Revenue 53 62 72
Gross Profit 128 159 124
Period Ending Mar 31, 2012 Dec 31, 2011 Mar 31, 2011
Total Revenue 181 221 196
Cost of Revenue 53 62 72
Gross Profit 128 159 124